MycoBiomDB – Record Details (MyCo_1820)

Biomarker Record Details

Database ID: MyCo_1820
DB IDMyCo_1820
TitleIncreased Urine Interleukin-17 and Interleukin-22 Levels in Patients With Candidal Urinary Tract Infection
Year2018
PMID29421775
Fungal Diseases involvedCandiduria
Associated Medical ConditionUrinary Tract Infection
GenusCandida
Speciesglabrata
OrganismCandida glabrata
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceUrine
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameIL-17
Biomarker Full NameInterleukin-17
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationIran
CohortA case-control study was conducted on inpatients at Hashemi Nejad Kidney Center. Thirty-four patients were identified with Candida species in their urine samples (> 103 colony-forming units per milliliter and presence of Candida species only).
Cohort No.34
Age Group17-89
P Valuep=.04
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismCandiduria, the presence of Candida species in urine specimen, is a common finding in hospitalized patients. Candida albicans is the most frequent causative organism of candiduria. The host risk factors to develop candiduria include urinary catheter or urinary tract abnormality, older age, female sex, prior antibiotic use, hospitalization in intensive care units and diabetes mellitus. The majority of candiduric patients reveal no symptoms, while few numbers of them present symptoms such as fever, dysuria, and flank pain.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitseBioscence enzyme-linked immunosorbent assay kit (USA)
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone